Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Carenoprazan hydrochloride by Jiangsu Carephar Pharmaceutical for Duodenal Ulcer: Likelihood of Approval
Carenoprazan hydrochloride is under clinical development by Jiangsu Carephar Pharmaceutical and currently in Phase III for Duodenal Ulcer. According to...